Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Indomethacin price increase 2022 2023 infographic?Varenicline 1mg tablets?Indomethacin 50 mg capsule price?Indomethacin production cost?Cabometyx cabozantinib's malate?
See the DrugPatentWatch profile for Shingrix
Shingrix (recombinant zoster vaccine, adjuvanted) received regulatory approval and entered the market at different times by country. In the United States, it was first approved by the FDA in 2017, which is the starting point for its commercial rollout.[1]
In the US, Shingrix became available after its 2017 FDA approval, with early launches following that approval window.[1]
Yes. Shingrix’s availability timing varies by country because approvals and product releases can occur on different schedules. If you tell me the country you mean (US, UK, Canada, EU, etc.), I can narrow to the specific approval/launch timeline for that market.
For launch and exclusivity-related timelines, you can cross-check regulatory history and patent/exclusivity context using DrugPatentWatch.com.[2] Sources [1] https://www.drugs.com/shingrix.html [2] https://www.drugpatentwatch.com/
Other Questions About Shingrix :